Hypertension (high blood pressure) Board decisions

The Board granted an effective date of September 29, 2020, for the award of an initial 10 percent rating for hypertension.

The Board granted an initial 10 percent rating for hypertension and irritable bowel syndrome (IBS) based on the Veteran's need for continuous medication and symptoms, respectively.

The Board granted an earlier effective date of October 11, 2021, for the grant of individual unemployability (TDIU) and special monthly compensation based on persistent depressive disorder.

The Board granted readjudication of the claim for an acquired psychiatric disorder and denied service connection for sleep apnea, while remanding claims for hypertension and a chronic sleep condition.

The Board denied the Veteran's claim for a rating in excess of 10 percent for hypertension as the evidence did not show diastolic pressure predominantly 110 or more, or systolic pressure predominantly 200 or more.

The Board remands the claims for service connection for left and right leg disabilities, hypertension, and aneurysm due to a need for further development regarding potential radiation exposure.

The veteran and his attorney have withdrawn the appeals for service connection for hypertension and a neck disability.

The Board denied the Veteran's claim for service connection for hypertension as there was no evidence of a diagnosis or manifestation of hypertension during service, and the first diagnosis occurred approximately 9 years after separation from active service.

The Board remands the issue of entitlement to service connection for hypertension due to a pre-decisional duty to assist error.

The Board remands the claims for service connection for diabetes and hypertension due to an inadequate record regarding potential Agent Orange exposure.

The Board granted ratings for peripheral neuropathy in the upper and lower extremities, denied a compensable rating for hypertension, and granted service connection for anemia and erectile dysfunction as secondary conditions.

The Board granted the Veteran an initial rating of 10 percent for hypertension based on a history of diastolic pressure predominantly 100 or more that requires continuous medication for control.

The appeal for service connection for obstructive sleep apnea (OSA) was dismissed, and several other claims were remanded for further development.

The Board denied the Veteran's claim for a compensable evaluation for hypertension as the evidence did not show that his blood pressure readings met the criteria for a higher rating.

The Board granted an effective date of September 29, 2023 for the grants of service connection for bladder cancer, skin rash due to chemotherapy, residuals of prostate cancer, hypertension and erectile dysfunction.

The Board granted an effective date of April 26, 2021, but no earlier, for service connection for coronary artery disease and a 30 percent rating from January 30, 2023, for hiatal hernia with Barrett's metaplasia with gastroesophageal reflux disease (GERD), while denying an effective date prior to August 10, 2022, for service connection for hypertension.

The Board granted service connection for bilateral hearing loss, but remanded the claims for hypertension, a respiratory condition, arthritis, and an acquired psychiatric disorder due to further development needed.

The Board remands the claim for a new medical opinion to address the nature and etiology of the Veteran's cause of death, specifically regarding its relation to presumed herbicide agent exposure.

The Board denied the Veteran's claim for service connection for hypertension as there was no competent evidence of a current diagnosis during the claim period.

The Board denied the Veteran's claim for an initial compensable rating for hypertension as there was no evidence of diastolic pressure predominantly 100 or more, or systolic pressure predominantly 160 or more during the appeal period.